Skip to main content
Premium Trial:

Request an Annual Quote

Casdin Appointed to NCGR Board of Directors

Premium

SANTA FE, NM--The National Center for Genome Resources, a nonprofit provider of bioinformatics tools and public databases here, appointed Jeffrey Casdin, CEO of Casdin Capital Partners, to its board of directors. Casdin has been engaged in investment analysis of the biotechnology industry since 1985 as a publisher, research analyst, and portfolio manager. He has managed Casdin Capital Partners in New York since early 1997, and previously served as a first vice-president responsible for biotechnology investment research at Merrill Lynch, and as senior vice-president and managing director of Oppenheimer overseeing biotechnology research.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.